Health

  • August 24, 2026

    3 Firms Build Biotech Merger With $150M In Private Funding

    Biopharmaceutical company Werewolf Therapeutics and clinical-stage biotechnology firm Ambros Therapeutics have agreed to merge in an all-stock deal built by three law firms, and includes $150 million in private funding.

  • August 24, 2026

    Humana Strikes Deal To Wrap Up Nurse's FLSA Suit

    Humana Inc. and a nurse who sued the health insurer in Georgia federal court for allegedly skimping on overtime pay have reached a deal to bring her proposed collective action to a close.

  • August 24, 2026

    Ill. Won't Hold Religious Docs To 'Aid-In-Dying' Law, For Now

    Illinois agreed not to force a group of religious healthcare providers to refer patients to "medical aid in dying" services, a form of care recently legalized by the state allowing certain terminally ill individuals to seek prescriptions for lethal medication to bring about their death.

  • August 24, 2026

    AIG Owes Primary Coverage For $4.7M Ambulance Crash Deal

    An AIG unit owes primary coverage for a $4.75 million settlement of an underlying suit over an ambulance crash, a New Jersey federal court ruled, finding that a borough's coverage through a county joint insurance fund does not trigger an "other insurance" provision.

  • August 24, 2026

    Feds Propose New $103K Fee For H-1B Visa Petitions

    The Trump administration proposed a new rule Monday that would impose a roughly $103,000 fee for all H-1B visa petitions subject to government caps, separate from the $100,000 fee President Donald Trump announced last year via executive proclamation.

  • August 21, 2026

    75-Country Immigrant Visa Freeze Ruled 'Patently Unlawful'

    A New York federal judge on Friday struck down a U.S. Department of State policy that halted the issuance of visas to immigrants from 75 countries, finding the policy "patently unlawful" and in excess of Secretary of State Marco Rubio's statutory authority.

  • August 21, 2026

    Cytek Hit With $56M Verdict For Infringing Cell-Sorting Patent

    A Delaware federal jury Friday awarded roughly $36 million in damages to biomedical testing manufacturer Beckman Coulter after finding that Cytek Biosciences infringed one of its patents covering a technology that quickly analyzes single cells.

  • August 21, 2026

    Albertsons Twists Record In Opioid Trial Motion, Wash. Says

    Washington state is urging a Seattle judge to reject Albertsons' latest dismissal bid in a suit accusing the grocery giant of fueling the state's opioid epidemic, arguing the motion rehashes failed arguments and distorts evidence presented over the past five weeks in an ongoing bench trial.

  • August 21, 2026

    Trump Seeks Justices' Review Of DEI Grant Termination Case

    The Trump administration is urging the U.S. Supreme Court to review a Ninth Circuit decision requiring the federal government to reinstate research grants that were terminated due to presidential orders against diversity, equity and inclusion initiatives.

  • August 21, 2026

    Pharma Co. Loses Challenge To $3M Acne Drug Arb. Award

    A New York federal court confirmed an arbitrator's finding that Sun Pharmaceuticals breached an agreement with the owner of an acne drug by seeking regulatory approval to market a version of the drug in Canada, rejecting arguments that the arbitrator wrongly relied on extrinsic evidence.

  • August 21, 2026

    Hogan Lovells Helps Advance Gene Therapy For Rare Disease

    Hogan Lovells Cadwalader partner Blake Wilson found himself scrolling through LinkedIn one day, when a post caught his eye that would spark a multiyear pro bono effort and lead to a breakthrough treatment for a rare and fatal disorder affecting children.

  • August 21, 2026

    Texas Senior Community Says Ch. 11 Plan Is Best It Can Offer

    Houston-based senior living community The Buckingham urged a Texas bankruptcy judge on Friday to confirm its Chapter 11 liquidation plan and overrule an objection by unsecured creditors, saying the deal offers the best possible recoveries and contains permissible legal releases.

  • August 21, 2026

    UC Health Pension Plan Defeats Doc's Denied Benefits Suit

    An Ohio federal judge tossed a doctor's suit claiming he was wrongfully denied pension benefits when UC Health bungled his years of qualifying service, ruling the calculations that concluded he was not eligible for payments were fair game under the plan's terms.

  • August 21, 2026

    NJ Medicaid Fee Law Barred By ERISA, Trade Groups Argue

    A coalition of restaurant, retail and hotel industry groups has urged a New Jersey federal court to strike down a state law requiring businesses to pay a fine when their employees are enrolled in the state Medicaid program, arguing the statute conflicts with federal benefits law.

  • August 21, 2026

    OhioHealth Faces Suit Over Insurance Contract Terms

    An Ohio health system has been hit with a proposed class action over its contractual restraints that a union health plan alleges prevent cheaper insurance providers from gaining a foothold in the market.

  • August 21, 2026

    Patients Drop Data Breach Suit Against Medical Billing Co.

    A group of patients has dropped a lawsuit accusing a Georgia-based medical billing practice of failing to properly secure the personal information of patients and employees ahead of a September data breach.

  • August 21, 2026

    Bio-Techne Gives FTC More Time On $11.3B Merck Deal

    Life science tool company Bio-Techne has withdrawn and refiled its intent to merge with pharmaceutical giant Merck in an $11.3 billion deal in order to give the Federal Trade Commission more time to scrutinize the deal for competition concerns.

  • August 21, 2026

    Radiology Co. Board Members Can't Dodge ESOP Trial

    A Colorado federal judge declined Friday to let board members of radiology company Envision escape a suit headed to a bench trial over claims they orchestrated an inflated $163.7 million stock sale to an employee stock ownership plan, ruling it's too contested whether they had control of the deal.

  • August 21, 2026

    ICE Contractor Wins Partial Block Of Colo. Inspection Law

    A Colorado federal judge temporarily blocked part of a new state law imposing additional inspections and penalties on The GEO Group Inc.'s immigration detention facility in Aurora, finding the provisions likely unlawfully discriminate against the company as a federal contractor.

  • August 21, 2026

    Pa. Hospital Worker Sues Over Unpaid Campus Walking Time

    Over 1,000 hourly workers at a University of Pittsburgh Medical Center facility have accused the employer of requiring them to badge in only upon reaching their workstations, leaving them uncompensated for time spent walking to and from their posts, according to a suit filed in state court.

  • August 20, 2026

    Uber Gets Greenlight On Most Fraud Claims Against LA Firms

    A California federal judge Wednesday largely rejected two Los Angeles personal injury firms' attempts to ditch Uber's suit claiming it's being targeted by a scheme involving fraudulent personal injury claims, finding Uber has plausibly alleged that the firms schemed with a surgeon to rack up medical costs.

  • August 20, 2026

    Elevance Health Gets Final OK On $14.75M Nurse OT Deal

    A Virginia federal court granted final approval Thursday to a $14.75 million global settlement resolving five related suits against Elevance Health by nurses who accused the insurer of misclassifying them as exempt from overtime pay.

  • August 20, 2026

    USPTO Tells Fed. Circ. 'Settled Expectations' Is Constitutional

    The U.S. Patent and Trademark Office has urged the Federal Circuit to reject Google's constitutional challenge to the office's "settled expectations" policy of taking the age of patents into account when deciding whether to review them, saying the rule is "eminently rational."

  • August 20, 2026

    Canadian Bioscience Cos. Settle 'Fake' Fuel Trading Suit

    A Colorado state judge agreed to issue a stay and administratively close a case brought by two Canadian bioscience companies alleging that a Denver resident defrauded them out of nearly $1 million through "fake" fuel trading deals, amid an undisclosed agreement reached between the parties.

  • August 20, 2026

    Colo. Panel Says Pretrial Meeting Didn't Affect Med Mal Trial

    A Colorado state appeals court on Thursday rejected a man's bid for a new trial in his medical malpractice lawsuit in which jurors sided with his physicians, finding the man did not show that an ex parte meeting between defense counsel and his own surgeon affected the trial's outcome.

Expert Analysis

  • NC Dental Review Change Counters Tougher National Trend

    Author Photo

    North Carolina’s elimination of its prior review requirement for dental management agreements departs sharply from the national trend toward expanded corporate practice of medicine oversight, but stakeholders should not view this regulatory shift as a relaxation of compliance expectations, say attorneys at Holland & Knight.

  • DOJ Healthcare Declination Offers Self-Disclosure Checklist

    Author Photo

    The U.S. Department of Justice's declination of criminal charges against Campus Eye Management signals that its new self-disclosure policy provides a real path for healthcare companies to avoid criminal exposure, but that path is paved with speed, transparency and operational remediation, says Jonathan Porter at Husch Blackwell.

  • Series

    Being In A Band Made Me A Better Lawyer

    Author Photo

    Playing shows in storied New York City venues and rehearsing with my bandmates in poorly ventilated rooms helped develop the professional qualities I rely on as a litigator, including an ability to collaborate with strong-minded equals and the determination to treat each client with singular focus, says Eliad Shapiro at Herrick Feinstein.

  • Opinion

    Correctional Healthcare Requires Clearer Legal Standards

    Author Photo

    As the correctional healthcare industry increasingly faces financial instability due to litigation, the U.S. Bureau of Prisons should develop clear standards for constitutionally adequate care for incarcerated patients, says Susanne Moore at Blackstone Trial Group.

  • Mich. Ruling Gives Consumer Protection Law Its Teeth Back

    Author Photo

    The Michigan Supreme Court's recent decision in Attorney General v. Eli Lilly, overruling key holdings in two earlier cases, means that Michigan businesses can no longer defeat allegations of deceptive conduct under the state's consumer protection law simply by pointing to any governmental regulation of the business, say attorneys at DiCello Levitt.

  • Series

    Law School's Missed Lessons: Surviving A Long Trial

    Author Photo

    Most of law school trial advocacy is geared toward the sprint of trying a short case, but beyond managing a cross-examination or closing argument, effectively handling the marathon of a lengthy trial requires the ability to maintain composure, organization and credibility with the jury, says Mihir Elchuri at Hirschler.

  • AI Chatbot's Medical Claims Highlight Enforcement Risks

    Author Photo

    The Pennsylvania State Board of Medicine's recent lawsuit against Character Technologies, arguing that an artificial intelligence chatbot engaged in the unlicensed practice of medicine, may provide other state licensing boards with a road map for going after AI platforms, and counsel should advise clients to calibrate compliance accordingly, say attorneys at Cooley.

  • 7th Circ. Ruling May Reduce Litigation Risk For Text Marketers

    Author Photo

    The recent Seventh Circuit holding in Steidinger v. Blackstone Medical Services that unwanted marketing text messages are not telephone calls under the Telephone Consumer Protection Act may strengthen companies' responses to presuit demand letters and early-stage litigation claims premised on do-not-call text theories, say attorneys at Holland & Knight.

  • How Calif. Ruling Defines Drug Cos.' R&D Responsibilities

    Author Photo

    The California Supreme Court's recent ruling in the Gilead Tenofovir Cases, which held that drugmakers have no duty to bring allegedly safer alternatives to market more quickly, is a win for pharmaceutical companies — but not a grant of blanket immunity for all early-stage drug development decisions, say attorneys at King & Spalding.

  • Calif. Justices' Ruling Reshapes Midcase Appeal Strategy

    Author Photo

    The California Supreme Court's recent decision in Maniago v. Desert Cardiology Consultants holds that voluntary dismissal cannot be used as a shortcut to appellate review of interlocutory orders, resolving a long-running appellate split and pushing litigants to use alternative procedural tools, says Josh Patashnik at Ashurst Perkins Coie.

  • Midyear Trends, Takeaways As Securities Class Actions Surge

    Author Photo

    High numbers of securities class actions through June suggest filings will stay elevated, with factors like changing enforcement attitudes, media scrutiny and the proliferation of potential defendants serving as both cause and effect in increased litigation involving AI-related disclosures, health and tech companies, and foreign issuers, say attorneys at Alston & Bird.

  • Series

    Going To Hardcore Shows Makes Me A Better Lawyer

    Author Photo

    While government contracts law and the hardcore scene may seem entirely unrelated, in my experience, both are about community, focus, being prepared for the unexpected and managing chaos, says Isaac Natter at Fluet.

  • Brace For Expanding Scrutiny Of Dark Patterns In Healthcare

    Author Photo

    Recent reporting and regulatory developments highlight growing concern surrounding so-called dark patterns in healthcare — user interface designs that improperly influence consumer decision-making — and represent an important evolution of how healthcare professionals should evaluate consent processes, say attorneys at Clark Hill.

  • How Home Infusion Providers Can Adapt To Enrollment Pause

    Author Photo

    Recent Centers for Medicare & Medicaid Services moratoria on new enrollments of home health agencies, medical equipment companies and hospices make home infusion providers' compliance obligations more complex and ambiguous, requiring new careful consideration of specific enrollment requirements and limitations, say attorneys at Quarles & Brady.

  • AI Data Mining Is Changing FCA Enforcement

    Author Photo

    With False Claims Act investigations increasingly emerging from statistical anomalies identified by data miners, companies need to consider what conclusions an outsider armed with artificial intelligence might draw from public-facing data and be ready to explain any anomalies if questions arise, say attorneys at Cohen & Gresser.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here